萬洲(00288.HK)歐洲業務通過投資與西班牙肉製品生產商Argal結成戰略聯盟
萬洲國際(00288.HK)宣布,旗下史密斯菲爾德食品公司歐洲業務與西班牙的一家熟食冷肉和其他包裝肉製品生產商Argal Alimentation結成戰略聯盟。
作為聯盟的一部分,史密斯菲爾德食品公司將持有Argal 50.1%的股份,Argal現有股東將保留49.9%的股份。該協議基於中期發展計劃,並商定了聯合管理框架。
兩家公司將共同努力實現營運協同效應,並將Argal的業務拓展到新的市場。該合作致力於開拓公司發展機遇,公司團隊將是未來有機擴張及實施新舉措的重要基礎。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.